233 related articles for article (PubMed ID: 20634105)
1. Measuring the "unmeasurable": assessment of bone marrow response to therapy using FDG-PET in patients with lymphoma.
Goudarzi B; Jacene HA; Wahl RL
Acad Radiol; 2010 Sep; 17(9):1175-85. PubMed ID: 20634105
[TBL] [Abstract][Full Text] [Related]
2. Bone marrow 18F-fluoro-2-deoxy-D-glucose positron emission tomography/computed tomography cannot replace bone marrow biopsy in diffuse large B-cell lymphoma.
Adams HJ; Kwee TC; Fijnheer R; Dubois SV; Nievelstein RA; de Klerk JM
Am J Hematol; 2014 Jul; 89(7):726-31. PubMed ID: 24711255
[TBL] [Abstract][Full Text] [Related]
3. Prognostic value of bone marrow
Lee JW; Lee SC; Kim HJ; Lee SM
Hell J Nucl Med; 2017; 20(1):17-25. PubMed ID: 28315904
[TBL] [Abstract][Full Text] [Related]
4. Prognostic Importance of Bone Marrow Uptake on Baseline
Soydal C; Koksoy EB; Yasar A; Turgal E; Erdogan BD; Akbulut H; Kucuk NO
Cancer Biother Radiopharm; 2016 Dec; 31(10):361-365. PubMed ID: 27996313
[TBL] [Abstract][Full Text] [Related]
5. Early bone marrow metastasis detection: the additional value of FDG-PET/CT vs. CT imaging.
Evangelista L; Panunzio A; Polverosi R; Ferretti A; Chondrogiannis S; Pomerri F; Rubello D; Muzzio PC
Biomed Pharmacother; 2012 Sep; 66(6):448-53. PubMed ID: 22902054
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of bone marrow involvement in extranodal NK/T cell lymphoma by FDG-PET/CT.
Zhou Z; Chen C; Li X; Li Z; Zhang X; Chang Y; Lu L; Cui Y; Ma Y; Zhang M
Ann Hematol; 2015 Jun; 94(6):963-7. PubMed ID: 25547320
[TBL] [Abstract][Full Text] [Related]
7. [The role of FDG-PET in staging of lymphoma and evaluation of therapeutic efficiency].
Zhou LL; Wang C; Zhao JH; Yan SK; Gao YR; Cai Q; Jiang JL; Wan LP; Yang J; Wei J; Zhao M; Bai HT
Zhonghua Xue Ye Xue Za Zhi; 2009 Apr; 30(4):233-6. PubMed ID: 19731822
[TBL] [Abstract][Full Text] [Related]
8. FDG-PET in the detection of bone marrow disease in Hodgkin's disease and aggressive non-Hodgkin's lymphoma and its impact on clinical management.
Pelosi E; Penna D; Deandreis D; Chiappella A; Skanjeti A; Vitolo U; Bisi G
Q J Nucl Med Mol Imaging; 2008 Mar; 52(1):9-16. PubMed ID: 18235420
[TBL] [Abstract][Full Text] [Related]
9. PET/CT predicts bone marrow involvement in paediatric non-Hodgkin lymphoma and may preclude the need for bone marrow biopsy in selected patients.
Chen S; Wang S; He K; Ma C; Fu H; Wang H
Eur Radiol; 2018 Jul; 28(7):2942-2950. PubMed ID: 29383519
[TBL] [Abstract][Full Text] [Related]
10. 18F-FDG PET/CT for monitoring the response of lymphoma to radioimmunotherapy.
Jacene HA; Filice R; Kasecamp W; Wahl RL
J Nucl Med; 2009 Jan; 50(1):8-17. PubMed ID: 19091903
[TBL] [Abstract][Full Text] [Related]
11. FDG PET/CT versus CT, MR imaging, and 67Ga scintigraphy in the posttherapy evaluation of malignant lymphoma.
Okada M; Sato N; Ishii K; Matsumura K; Hosono M; Murakami T
Radiographics; 2010; 30(4):939-57. PubMed ID: 20631361
[TBL] [Abstract][Full Text] [Related]
12. Diagnostic performance of 18F-2-fluoro-2-deoxy-D-glucose PET/computerized tomography in identifying bone marrow infiltration in new patients with diffuse large B-cell lymphoma and Hodgkin lymphoma.
Kandeel AA; Hussein M; Zidan L; Younis J; Edesa W; Alsayed Y
Nucl Med Commun; 2020 Mar; 41(3):269-279. PubMed ID: 31895758
[TBL] [Abstract][Full Text] [Related]
13. The utility of 18-F-fluorodeoxyglucose positron emission tomography in evaluation of bone marrow involvement by non-Hodgkin lymphoma.
Muslimani AA; Farag HL; Francis S; Spiro TP; Chaudhry AA; Chan VC; Taylor HC; Daw HA
Am J Clin Oncol; 2008 Oct; 31(5):409-12. PubMed ID: 18838874
[TBL] [Abstract][Full Text] [Related]
14. [Prognostic value of bone marrow (18)F-FDG uptake pattern of pretreatment PET-CT in extranodal NK/T cell lymphoma].
Zhang Y; Zhou J; Wang L; Li JY; Ding CY
Zhonghua Zhong Liu Za Zhi; 2020 Oct; 42(10):885-890. PubMed ID: 33113633
[No Abstract] [Full Text] [Related]
15. 18F-FDG PET/CT and 123I-metaiodobenzylguanidine imaging in high-risk neuroblastoma: diagnostic comparison and survival analysis.
Papathanasiou ND; Gaze MN; Sullivan K; Aldridge M; Waddington W; Almuhaideb A; Bomanji JB
J Nucl Med; 2011 Apr; 52(4):519-25. PubMed ID: 21421719
[TBL] [Abstract][Full Text] [Related]
16. FDG PET for Evaluation of Bone Marrow Status in T-Cell Lymphoma.
Koh Y; Lee JM; Woo GU; Paeng JC; Youk J; Yoon SS; Kim I; Kang KW
Clin Nucl Med; 2019 Jan; 44(1):4-10. PubMed ID: 30371574
[TBL] [Abstract][Full Text] [Related]
17. F-18 FDG uptake of bone marrow on PET/CT scan: it's correlation with CD38/CD138 expressing myeloma cells in bone marrow of patients with multiple myeloma.
Ak I; Gulbas Z
Ann Hematol; 2011 Jan; 90(1):81-7. PubMed ID: 20690019
[TBL] [Abstract][Full Text] [Related]
18. 18F-FDG super bone marrow uptake: A highly potent indicator for the malignant infiltration.
Alam MS; Fu L; Ren YY; Wu HB; Wang QS; Han YJ; Zhou WL; Li HS; Wang Z
Medicine (Baltimore); 2016 Dec; 95(52):e5579. PubMed ID: 28033252
[TBL] [Abstract][Full Text] [Related]
19. Role of FDG-PET/CT in detecting lymphomatous bone marrow involvement in patients with newly diagnosed diffuse large B-cell lymphoma.
Hong J; Lee Y; Park Y; Kim SG; Hwang KH; Park SH; Jeong J; Kim KH; Ahn JY; Park S; Park J; Lee JH
Ann Hematol; 2012 May; 91(5):687-695. PubMed ID: 22008868
[TBL] [Abstract][Full Text] [Related]
20. Correcting tumour SUV for enhanced bone marrow uptake: retrospective 18F-FDG PET/CT studies.
Teo BK; Badiee S; Hadi M; Lam T; Johnson L; Seo Y; Bacharach SL; Hasegawa BH; Franc BL
Nucl Med Commun; 2008 Apr; 29(4):359-66. PubMed ID: 18317301
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
